QQQ   314.13 (+0.45%)
AAPL   161.52 (+0.47%)
MSFT   282.08 (+0.56%)
META   206.49 (+0.56%)
GOOGL   100.60 (-0.78%)
AMZN   101.27 (+1.02%)
TSLA   195.62 (+0.90%)
NVDA   272.26 (+0.90%)
NIO   10.47 (+6.51%)
BABA   103.18 (+3.26%)
AMD   97.81 (+1.79%)
T   19.03 (+0.16%)
F   12.25 (+1.66%)
MU   62.89 (-1.02%)
CGC   1.77 (-2.21%)
GE   94.04 (-0.02%)
DIS   97.84 (+1.00%)
AMC   4.94 (-1.20%)
PFE   40.31 (+0.15%)
PYPL   74.02 (-0.22%)
NFLX   336.87 (+1.46%)
QQQ   314.13 (+0.45%)
AAPL   161.52 (+0.47%)
MSFT   282.08 (+0.56%)
META   206.49 (+0.56%)
GOOGL   100.60 (-0.78%)
AMZN   101.27 (+1.02%)
TSLA   195.62 (+0.90%)
NVDA   272.26 (+0.90%)
NIO   10.47 (+6.51%)
BABA   103.18 (+3.26%)
AMD   97.81 (+1.79%)
T   19.03 (+0.16%)
F   12.25 (+1.66%)
MU   62.89 (-1.02%)
CGC   1.77 (-2.21%)
GE   94.04 (-0.02%)
DIS   97.84 (+1.00%)
AMC   4.94 (-1.20%)
PFE   40.31 (+0.15%)
PYPL   74.02 (-0.22%)
NFLX   336.87 (+1.46%)
QQQ   314.13 (+0.45%)
AAPL   161.52 (+0.47%)
MSFT   282.08 (+0.56%)
META   206.49 (+0.56%)
GOOGL   100.60 (-0.78%)
AMZN   101.27 (+1.02%)
TSLA   195.62 (+0.90%)
NVDA   272.26 (+0.90%)
NIO   10.47 (+6.51%)
BABA   103.18 (+3.26%)
AMD   97.81 (+1.79%)
T   19.03 (+0.16%)
F   12.25 (+1.66%)
MU   62.89 (-1.02%)
CGC   1.77 (-2.21%)
GE   94.04 (-0.02%)
DIS   97.84 (+1.00%)
AMC   4.94 (-1.20%)
PFE   40.31 (+0.15%)
PYPL   74.02 (-0.22%)
NFLX   336.87 (+1.46%)
QQQ   314.13 (+0.45%)
AAPL   161.52 (+0.47%)
MSFT   282.08 (+0.56%)
META   206.49 (+0.56%)
GOOGL   100.60 (-0.78%)
AMZN   101.27 (+1.02%)
TSLA   195.62 (+0.90%)
NVDA   272.26 (+0.90%)
NIO   10.47 (+6.51%)
BABA   103.18 (+3.26%)
AMD   97.81 (+1.79%)
T   19.03 (+0.16%)
F   12.25 (+1.66%)
MU   62.89 (-1.02%)
CGC   1.77 (-2.21%)
GE   94.04 (-0.02%)
DIS   97.84 (+1.00%)
AMC   4.94 (-1.20%)
PFE   40.31 (+0.15%)
PYPL   74.02 (-0.22%)
NFLX   336.87 (+1.46%)
NASDAQ:NTLA

Intellia Therapeutics - NTLA Institutional Ownership

$35.95
-1.61 (-4.29%)
(As of 03/30/2023 01:57 PM ET)
Add
Compare
Today's Range
$35.88
$38.26
50-Day Range
$33.30
$44.82
52-Week Range
$32.44
$78.58
Volume
394,513 shs
Average Volume
1.16 million shs
Market Capitalization
$3.16 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$87.18

Institutional Ownership Changes (13F Filings) for Intellia Therapeutics (NASDAQ:NTLA)

Current
Institutional Ownership
Percentage
85.61%
Number of
Institutional Buyers
(last 12 months)
217
Total
Institutional Inflows
(last 12 months)
$910.38 M
Number of
Institutional Sellers
(last 12 months)
129
Total
Institutional Outflows
(last 12 months)
$443.11 M
Skip Chart & View Institutional Buying and Selling Data

NTLA Institutional Buying and Selling by Quarter

Get NTLA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Intellia Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Intellia Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/23/2023MetLife Investment Management LLC44,031$1.54M0.0%+9.8%0.050%
3/6/2023Rockefeller Capital Management L.P.23,361$0.82M0.0%-23.4%0.027%
2/28/2023Voya Investment Management LLC112,076$3.91M0.0%+2.8%0.127%
2/24/2023Natixis3,814$0.13M0.0%-8.4%0.005%
2/21/2023Macquarie Group Ltd.20,000$0.70M0.0%-2.3%0.025%
2/16/2023Axxcess Wealth Management LLC14,174$0.50M0.0%-21.7%0.018%
2/16/2023Alliancebernstein L.P.1,689,722$58.95M0.0%+18.8%2.148%
2/15/2023Steward Partners Investment Advisory LLC2,096$73K0.0%-12.2%0.003%
2/15/2023Metropolitan Life Insurance Co NY5,251$0.18M0.0%+15.5%0.007%
2/15/2023MetLife Investment Management LLC44,031$1.54M0.0%+9.8%0.056%
2/15/2023Capital Impact Advisors LLC10,705$0.37M0.4%-10.4%0.014%
2/15/2023Lazard Asset Management LLC47,507$1.66M0.0%-45.6%0.060%
2/15/2023Silverarc Capital Management LLC32,770$1.14M0.3%+2.4%0.042%
2/15/2023State of Wisconsin Investment Board68,629$2.39M0.0%+0.4%0.087%
2/15/2023Sandia Investment Management LP1,000$35K0.0%N/A0.001%
2/15/2023Squarepoint Ops LLC91,124$3.18M0.0%+1,348.7%0.116%
2/15/2023T. Rowe Price Investment Management Inc.533,617$18.62M0.0%-0.2%0.678%
2/15/2023Legal & General Group Plc72,417$2.53M0.0%+5.7%0.092%
2/15/2023Morgan Stanley2,518,150$87.86M0.0%+64.5%3.200%
2/15/2023Man Group plc30,465$1.06M0.0%+39.4%0.039%
2/15/2023Mariner LLC13,175$0.46M0.0%-2.7%0.017%
2/15/2023Nomura Holdings Inc.568,952$19.83M0.1%+235.1%0.723%
2/15/2023Norges Bank857,278$29.91M0.0%N/A1.090%
2/15/2023E Fund Management Co. Ltd.11,103$0.39M0.0%+50.2%0.014%
2/15/2023Eagle Asset Management Inc.187,365$6.49M0.0%-3.9%0.238%
2/15/2023Echo Street Capital Management LLC22,392$0.78M0.0%+237.1%0.028%
2/15/2023Endurant Capital Management LP16,401$0.57M0.2%N/A0.021%
2/15/2023Atom Investors LP9,767$0.34M0.2%-34.5%0.012%
2/15/2023Avidity Partners Management LP638,200$22.27M0.5%-36.1%0.811%
2/15/2023Axxcess Wealth Management LLC14,174$0.50M0.0%-21.7%0.018%
2/15/2023Jefferies Financial Group Inc.10,339$38K0.0%N/A0.013%
2/15/2023ICA Group Wealth Management LLC1,766$62K0.0%N/A0.002%
2/14/2023Vident Investment Advisory LLC6,606$0.23M0.0%N/A0.008%
2/14/2023Price T Rowe Associates Inc. MD1,929,355$67.32M0.0%+11.1%2.452%
2/14/2023Amundi16,936$0.64M0.0%-27.7%0.022%
2/14/2023Marshall Wace LLP389,074$13.58M0.0%+5,157.8%0.495%
2/14/2023Two Sigma Advisers LP582,217$20.31M0.1%-0.3%0.740%
2/14/2023Campbell & CO Investment Adviser LLC14,768$0.52M0.1%N/A0.019%
2/14/2023Two Sigma Investments LP200,414$6.99M0.0%+118.8%0.255%
2/14/2023Granahan Investment Management LLC217,623$7.59M0.2%+44.3%0.277%
2/14/2023Engineers Gate Manager LP38,567$1.35M0.1%+35.5%0.049%
2/14/2023Penserra Capital Management LLC5,620$0.20M0.0%-35.9%0.007%
2/14/2023Triatomic Management LP20,000$0.70M0.6%N/A0.025%
2/13/2023Gyon Technologies Capital Management LP7,753$0.27M0.1%N/A0.010%
2/13/2023Advisors Asset Management Inc.6,623$0.23M0.0%+51.7%0.008%
2/13/2023Charles Schwab Investment Management Inc.892,631$31.14M0.0%+15.6%1.135%
2/13/2023Deutsche Bank AG155,710$5.43M0.0%+6.2%0.198%
2/13/2023Nikko Asset Management Americas Inc.2,976,002$103.74M1.5%+0.4%3.782%
2/13/2023Wells Fargo & Company MN70,086$2.45M0.0%-25.5%0.089%
2/13/2023Barclays PLC259,867$9.07M0.0%+40.8%0.330%
2/13/2023The Manufacturers Life Insurance Company 63,847$2.24M0.0%+17.9%0.081%
2/13/2023Seven Eight Capital LP13,464$0.47M0.1%N/A0.017%
2/13/2023ExodusPoint Capital Management LP9,982$0.35M0.0%-41.9%0.013%
2/13/2023Picton Mahoney Asset Management15,902$0.56M0.0%+3.2%0.020%
2/13/2023Credit Suisse AG92,557$3.23M0.0%+11.5%0.118%
2/13/2023Neuberger Berman Group LLC108,350$3.78M0.0%-22.4%0.138%
2/13/2023Geode Capital Management LLC1,591,847$55.54M0.0%+15.8%2.023%
2/13/2023American Century Companies Inc.331,484$11.57M0.0%+23.6%0.421%
2/13/2023GSA Capital Partners LLP14,355$0.50M0.1%+37.9%0.018%
2/13/2023Capital Fund Management S.A.109,889$3.83M0.0%N/A0.140%
2/13/2023JPMorgan Chase & Co.662,617$23.12M0.0%+3.4%0.842%
2/13/2023Teacher Retirement System of Texas20,644$0.72M0.0%-7.3%0.026%
2/10/2023Bank of America Corp DE687,785$24M0.0%+128.6%0.874%
2/10/2023American International Group Inc.40,202$1.40M0.0%+12.3%0.051%
2/10/2023Amalgamated Bank13,125$0.46M0.0%+15.6%0.017%
2/10/2023Schroder Investment Management Group107,614$3.76M0.0%+28.3%0.137%
2/10/2023AXQ Capital LP12,633$0.44M0.3%N/A0.016%
2/10/2023Victory Capital Management Inc.25,295$0.88M0.0%-2.1%0.029%
2/10/2023Franklin Resources Inc.10,790$0.38M0.0%+2.8%0.014%
2/10/2023Advisor Group Holdings Inc.20,314$0.71M0.0%+167.6%0.026%
2/10/2023Aigen Investment Management LP10,383$0.36M0.1%N/A0.013%
2/10/2023Discovery Value Fund572,950$19.99M5.8%-2.0%0.728%
2/10/2023Blair William & Co. IL7,360$0.26M0.0%-30.2%0.009%
2/10/2023CI Investments Inc.2,400$84K0.0%+517.0%0.003%
2/10/2023Moors & Cabot Inc.2,800$0.33M0.0%N/A0.004%
2/9/2023Chevy Chase Trust Holdings LLC972,076$33.92M0.1%-14.5%1.235%
2/9/2023Mirae Asset Global Investments Co. Ltd.208,271$7.27M0.0%-1.5%0.265%
2/9/2023Itau Unibanco Holding S.A.2,510$89K0.0%+90.0%0.003%
2/9/2023Victory Capital Management Inc.25,215$1.07M0.0%-2.4%0.032%
2/9/2023Dimensional Fund Advisors LP920,076$32.10M0.0%+1.1%1.169%
2/9/2023Principal Financial Group Inc.19,835$0.69M0.0%+6.7%0.025%
2/9/2023Citigroup Inc.99,121$3.46M0.0%-15.1%0.126%
2/9/2023HighTower Advisors LLC26,087$0.91M0.0%-6.1%0.033%
2/8/2023Raymond James Financial Services Advisors Inc.23,230$0.81M0.0%-9.6%0.030%
2/8/2023Raymond James & Associates21,100$0.74M0.0%+15.1%0.027%
2/8/2023UBS Group AG181,611$6.34M0.0%+270.9%0.231%
2/8/2023Skandinaviska Enskilda Banken AB publ 15,700$0.55M0.0%-5.5%0.020%
2/8/2023Van ECK Associates Corp93,690$3.27M0.0%+48.5%0.119%
2/8/2023California Public Employees Retirement System146,588$5.11M0.0%-6.6%0.186%
2/8/2023Swiss National Bank165,200$5.76M0.0%+2.0%0.210%
2/8/2023Russell Investments Group Ltd.76,398$2.67M0.0%-7.2%0.097%
2/8/2023Arizona State Retirement System19,303$0.67M0.0%+4.0%0.025%
2/7/2023State Board of Administration of Florida Retirement System23,458$0.82M0.0%-5.6%0.030%
2/7/2023Commonwealth Equity Services LLC27,186$0.95M0.0%+46.4%0.035%
2/7/2023LPL Financial LLC35,991$1.26M0.0%-9.5%0.046%
2/7/2023Shell Asset Management Co.1,698$59K0.0%-16.8%0.002%
2/7/2023Handelsbanken Fonder AB10,800$0.38M0.0%+13.7%0.014%
2/7/2023Envestnet Asset Management Inc.18,534$0.65M0.0%-11.5%0.024%
2/7/2023TD Asset Management Inc49,449$1.73M0.0%+9.2%0.063%
2/7/2023Moors & Cabot Inc.2,800$0.33M0.0%N/A0.004%
(Data available from 1/1/2016 forward)













NTLA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of NTLA shares?

During the previous two years, 422 institutional investors and hedge funds held shares of Intellia Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($370.31M), BlackRock Inc. ($342.93M), ARK Investment Management LLC ($328.69M), Viking Global Investors LP ($179.41M), FMR LLC ($171.09M), State Street Corp ($150.41M), and Sumitomo Mitsui Trust Holdings Inc. ($103.83M).Learn more on NTLA's institutional investors.

What percentage of Intellia Therapeutics stock is owned by institutional investors?

85.61% of Intellia Therapeutics stock is owned by institutional investors. Learn more on NTLA's institutional investor holdings.

Which institutional investors have been buying Intellia Therapeutics stock?

Of the 384 institutional investors that purchased Intellia Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: ARK Investment Management LLC ($2.91M), Alliancebernstein L.P. ($2.22M), FMR LLC ($2.09M), Morgan Stanley ($1.82M), State Street Corp ($1.48M), Federated Hermes Inc. ($1.22M), and Viking Global Investors LP ($1.19M).

How much institutional buying is happening at Intellia Therapeutics?

Institutional investors have bought a total of 38,976,955 shares in the last 24 months. This purchase volume represents approximately $3.61B in transactions.

Which Intellia Therapeutics major shareholders have been selling company stock?

Of the 217 institutional investors that sold Intellia Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: ARK Investment Management LLC ($3.74M), Nikko Asset Management Americas Inc. ($2.80M), Sumitomo Mitsui Trust Holdings Inc. ($2.80M), Jennison Associates LLC ($0.93M), Invesco Ltd. ($0.84M), Alliancebernstein L.P. ($0.83M), and Victory Capital Management Inc. ($0.74M).

How much institutional selling is happening at Intellia Therapeutics?

Institutional investors have sold a total of 23,061,798 shares in the last 24 months. This volume of shares sold represents approximately $2.50B in transactions.

This page (NASDAQ:NTLA) was last updated on 3/30/2023 by MarketBeat.com Staff